SCHEMBL6860468

SCHEMBL6860468

CC(C)(C)N1CCCN(c2ccc(S(=O)(=O)Nc3ccccc3)cc2N)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
MEN1 O00255 3/20 0.59
L3MBTL1 Q9Y468 3/20 0.54
GAA P10253 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 3/20 0.50
PKM P14618 1/20 0.50
MAPT P10636 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
TP53 P04637 1/20 0.48
HTT P42858 1/20 0.48
ALDH1A1 P00352 1/20 0.45
RAB9A P51151 1/20 0.44
ADRB2 P07550 3/20 0.43
ADRB1 P08588 3/20 0.43
ADRB3 P13945 2/20 0.43
POLB P06746 1/20 0.41
HTR1A P08908 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3619643 0.86 SMN1; SMN2 (0.64) KMT2AMEN1L3MBTL1GAASMN1; SMN2
SCHEMBL6751632 0.85 LMNA (0.48) KMT2AMEN1L3MBTL1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL3616820 0.85 SMN1; SMN2 (0.63) KMT2AMEN1L3MBTL1GAASMN1; SMN2
SCHEMBL3610935 0.82 MEN1 (0.56) KMT2AMEN1L3MBTL1GAASMN1; SMN2
SCHEMBL3616972 0.80 MEN1 (0.57) KMT2AMEN1L3MBTL1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL3619589 0.79 MEN1 (0.56) KMT2AMEN1L3MBTL1GAASMN1; SMN2
SCHEMBL3615480 0.79 MEN1 (0.59) KMT2AMEN1L3MBTL1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL3616793 0.78 MEN1 (0.58) KMT2AMEN1L3MBTL1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL3624280 0.78 MEN1 (0.57) KMT2AMEN1L3MBTL1GAASMN1; SMN2
SCHEMBL4310249 0.74 KMT2A (0.50) KMT2AMEN1L3MBTL1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406884-A1 ARYLSUSFONAMIDE COMPOUNDS FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS-DISORDERS BIOVITRUM AB (SE) 2004-04-14 EP disclosed
WO-2002092585-A1 NOVEL, ARYLSUSFONAMIDE COMPOUNDS FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS-DISORDERS BIOVITRUM AB (SE) 2002-11-21 WO disclosed